References

Abramova, F.A., Grinberg, L.M., Yampolskaya, O., et al. (1993). Pathology of inhalational anthrax in forty-two cases from the Sverdlovsk outbreak of 1979. Proceedings of the National Academy of Sciences of the United States of America 90, 2291-2294.

Abu-Amr, Z. (1993). Hamas: A historical and political background. Journal of Palestine Studies 22, 5-19.

Ales, N.C. and Katial, R.K. (2004). Vaccines against biologic agents: uses and developments. Respiratory Care Clinics 10, 123-146.

Alibek, K. (1999). Biohazard. New York: Random House.

Arena, M.P. and Arrigo, B.A. (2005). Social psychology, terrorism, and identity: a preliminary re-examination of theory, culture, self, and society. Behavioral Sciences and the Law 23, 485-506.

Arnon, S.S., Schechter, R., Inglesby, T.V et al. (2001). Botulinum toxin as a biological weapon: medical and public health management. Journal of the American Medical Association 285, 1059-1070.

Artenstein, A.W. (2003). Biodefense: medicine in the time of bioterrorism. Medicine and Health/Rhode Island86, 201-203.

Artenstein, A.W. (2004a). Bioterrorism and biodefense. In: J. Cohen, W.C. Powderly, S.F. Berkley et al. (eds), Infectious Diseases, 2nd edn. London: Mosby, pp. 99-107.

Artenstein, A.W. (2004b). Initial management of a suspected outbreak of smallpox. In: J. Cohen, W.C. Powderly, S.F. Berkley et al. (eds), Infectious Diseases, 2nd edn. London: Mosby, pp. 1022-1024.

Artenstein, A.W. (2006). Biologic attack. In: G.R. Ciottone, P.D. Anderson, auf der Heide, E. et al. (eds), Disaster Medicine. Philadelphia: Mosby, pp. 415-423.

Artenstein, A.W. and Lucey, D.R. (2000). Occupational plague. In: A.J. Couturier (ed.), Occupational and Environmental Infectious Diseases. Beverly: OEM Press, pp. 329-335.

Artenstein, A.W., Neill, M.A. and Opal, S.M. (2002a). Bioterrorism and physicians. Annals of Internal Medicine 137, 626.

Artenstein, A.W., Neill, M.A. and Opal, S.M. (2002b). Bioterrorism and physicians. Medicine and Health/Rhode Island 85, 74-77.

Artenstein, A.W., Opal, S.M., Cristofaro, P. et al. (2004). Chloroquine enhances survival in Bacillus anthracis intoxication. Journal of Infectious Diseases 190, 1655-1660.

Artenstein, A.W., Johnson, C., Marbury, T.C. et al. (2005). A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults. Vaccine 23, 2203-2209.

Barakat, L.A., Quentzel, H.L., Jernigan, J.A. et al. (2002). Fatal inhalational anthrax in a 94-year-old Connecticut woman. Journal of the American Medical Association 287, 863-868.

Barlett, J.G. and Hayden, F.G. (2005) Influenza A (H5N1): will it be the next pandemic influenza? Are we ready? Annals of Internal Medicine 143(6), 460-462.

Bell, D.M., Kozarsky, P.E. and Stephens, D.S. (2002). Conference summary: clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerging Infectious Diseases 8, 222-223.

Bhalla, D.K. and Warheit, D.B. (2004). Biological agents with potential for misuse: a historical perspective and defensive measures. Toxicology and Applied Pharmacology 199, 71-84.

Black, J.L. (2003). Genome projects and gene therapy: gateways to next generation biological weapons. Military Medicine 168, 864-871.

Bleck, T.P. (2005). Botulinum toxin as a biological weapon. In: G.L. Mandell, J.E. Bennett and R. Dolin (eds.), Principles and Practice of Infectious Diseases, 6th edn. Philadelphia: Elsevier, pp. 3624-3625.

Borio, L., Inglesby, T., Peters, C.J., et al. (2002). Hemorrhagic fever viruses as biological weapons: medical and public health management. Journal of the American Medical Association 287, 2391-2405.

Borum, R. and Gelles, M. (2005). Al-Qaeda's operational evolution: behavioral and organizational perspectives. Behavioral Sciences and the Law 23, 467-483.

Bozzette, S.A., Boer, R., Bhatnagar, V et al. (2003). A model for a smallpox-vaccination policy. New England Journal of Medicine 348, 416-425.

Breman, J.G. and Henderson, D.A. (2002). Diagnosis and management of smallpox. New England Journal of Medicine 346, 1300-1308.

Brey, R.N. (2005). Molecular basis for improved anthrax vaccines. Advanced Drug Delivery Reviews 57(9), 1266-1292.

Burke, D.S. (1977). Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory acquired tularemia. Journal of Infectious Diseases 135, 55-60.

Bush, L.M., Abrams, B.H., Beall, A. et al. (2001). Index case of fatal inhalational anthrax due to bioterrorism in the United States. New England Journal of Medicine 345, 1607-1610.

Byrne, M.P. and Smith, L.A. (2000). Development of vaccines for prevention of botulism. Biochemie 82, 955-966.

Centers for Disease Control and Prevention (1996). Prevention of plague: recommendations of the Advisory Committee on immunization practices (ACIP). Mortality and Morbidity Weekly Report 45(RR-14), 1-15.

Centers for Disease Control and Prevention (2000). Biological and chemical terrorism: strategic plan for preparedness and response. Mortality and Morbidity Weekly Report 49(RR-4), 1-14.

Centers for Disease Control and Prevention (2001). Considerations for distinguishing influenza-like illness from inhalational anthrax. Mortality and Morbidity Weekly Report 50, 984-986.

Centers for Disease Control and Prevention (2003). Recommendations for using smallpox vaccine in a pre-event vaccination program. Mortality and Morbidity Weekly Report 52(RR-7), 1-14.

Center for Nonproliferation Studies at the Monterey Institute of International Studies (2002). Chemical and Biological Weapons: Possession and Programs Past and Present. Available at: http://cns.miis.edu/research/cbw.possess.htm (accessed 3 April 2006).

Christopher, G.W., Cieslak, T.J., Pavlin, J.A. et al. (1997). Biological warfare: a historical perspective. Journal of the American Medical Association 278, 412-417.

Cieslak, T.J., Christopher, G.W., Kortepeter, M.G. et al. (2000). Immunization against potential biological warfare agents. Clinical Infectious Diseases 30, 843-850.

Cosgrove, S.E., Perl, T.M., Song, X. et al. (2005). Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Archives of Internal Medicine 165, 2002-2006.

Davidson, L. (1998). Islamic Fundamentalism. Westport: Greenwood.

Dennis, D.T., Inglesby, T.V, Henderson, D.A. et al. (2001). Tularemia as a biological weapon: medical and public health management. Journal of the American Medical Association 285, 2763-2773.

Dixon, T.C., Meselson, M., Guillemin, J. et al. (1999). Anthrax. New England Journal of Medicine 341, 815-826.

Eigelsbach, H.T. and Down, C.M. (1961). Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. Journal of Immunology 87, 415-425.

Eigelsbach, H., Tulis, H., Overholt, E. et al. (1961). Aerogenic immunization of the monkey and guinea pig with live tularemia vaccine. Proceedings of the Society of Experimental Biology and Medicine 108, 732-734.

Faden, R.R., Taylor, H.A. and Keirer, N.K. (2003). Consent and compensation: a social compact for smallpox vaccine policy in the event of an attack. Clinical Infectious Diseases 36, 1547-1551.

Fauci, A.S. (2006). Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. Cell 124, 665-670.

Fenner, F., Henderson, D.A., Arita, I. et al. (1988). Smallpox and its Eradication. Geneva: World Health Organization.

Franz, D.R. and Zajtchuk, R. (2002). Biological terrorism: understanding the threat, preparation, and medical response. Disease-a-Month 48(8), 490-564.

Fraser, C. (2004). A genomics-based approach to biodefence preparedness. Nature Reviews 5, 23-33.

Freedman, A., Afonja, O., Chang, M.W. et al. (2002). Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. Journal of the American Medical Association 287, 869-874.

Friedlander, A.M., Pittman, P.R. and Parker, G.W. (1999). Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. Journal of the American Medical Association 282, 2104-2106.

Friedlander, A.M. (2001). Tackling anthrax. Nature 414, 160-161.

Galea, S., Ahern, J., Resnick, H. et al. (2002). Psychological sequelae of the September 11 terrorist attacks in New York City. New England Journal of Medicine 346, 982-987.

Galimand, M., Cuiyoule, A., Gerbaud, G. et al. (1997). Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. New England Journal of Medicine 337, 677-680.

Galvani, A.P. and Slatkin, M. (2003). Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proceedings of the National Academy ofSciences 100(25), 15,276-15,279.

Gursky, E. Inglesby, T.V. and O'Toole, T. (2003). Anthrax 2001: observations on the medical and public health response. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 1 (2), 97-110.

Grabenstein, J. and Winkenwerder, W. (2003). US military smallpox vaccination program experience. Journal of the American Medical Association 289, 3278-3282.

Guillemin, J. (1999). Anthrax: The Investgation of a Deadly Outbreak. Berkeley: University of California Press.

Harris, S.H. (1994). Factories of Death: Japanese Biological Warfare, 1932-45, and the American Cover-up. New York: Routledge.

Hatheway, C.L. (1976). Toxoid of Clostridium outline: purification and immunization studies. Applied Environmental Microbiology 31, 234-242.

Henderson, D.A., Inglesby, T.V, Bartlett, J.G. et al. (1999). Smallpox as a biological weapon: medical and public health management; working group on civilian biodefense. Journal of the American Medical Association 281, 2127-2137.

Henderson, D.W., Peacock, S. and Belton, F.C. (1956). Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. Journal of Hygiene 54, 28-38.

Hermanson G., Whitlow V., Parker S. et al. (2004). A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. Proceedings of the National Academy of Science 101, 13,601-13,606.

Heyman, D. (2002). Lessons from the Anthrax Attacks. Washington, DC: Center for Strategic and International Studies.

Hornick, R.B. and Eigelsbach, H.T. (1966). Aerogenic immunization of man with live tularemia vaccine. Bacteriological Reviews 30, 532-538.

Hupert, N., Bearman, G., Mushlin, A. et al. (2003). Accuracy of screening for inhalational anthrax after a bioterrorist attack. Annals oflnternalMedicine 139, 337-345.

Inglesby, T.V, Henderson, D.A., Bartlett, J.G. et al. (1999). Anthrax as a biological weapon: medical and public health management. Journal of the American Medical Association 281, 1735-1745.

Inglesby, T.V., Dennis, D.T., Henderson, D.A. et al. (2000). Plague as a biological weapon: medical and public health management. Journal of the American Medical Association 283, 2281-2290.

Inglesby, T.V., O'Toole, T., Henderson, D.A. et al. (2002). Anthrax as a biological weapon, 2002: updated recommendations for management. Journal of the American Medical Association 287, 2236-2252.

Isherwood, K.E., Titball, R.W., Davies, D.H. et al. (2005). Vaccination strategies for Francisella tularensis. Advanced Drug Delivery Reviews 57, 1403-1414.

Jernigan, J., Stephens, D.S., Ashford, D.A. et al. (2001). Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerging Infectious Diseases 7, 933-944.

Kaplan, E.H., Craft, D.L. and Wein, L.M. (2002). Emergency response to a smallpox attack: the case for mass vaccination. Proceedings of the National Academy of Sciences 99, 10,935-10,940.

Karsenty, E., Shemer, J., Alshech, I. et al. (1991). Medical aspects of the Iraqi missile attacks on Israel. Israeli Journal of Medical Science 27, 603-607.

Lane, J.M., Ruben, F.L., Neff, J.M. et al. (1970). Complications of smallpox vaccination, 1968: results of ten statewide surveys. Journal of Infectious Diseases 120, 303-309.

Larsson, P., Oyston, P.C.F., Chain, P. et al. (2005) The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nature Genetics 37, 153-159.

Lee, J.S., Hadjipanayis, A.G. and Parker, M.D. (2005). Viral vectors for use in the development of biodefense vaccines. Advanced Drug Delivery Reviews 57, 1293-1314.

Lucey, D. (2005). Anthrax. In: G.L. Mandell, J.E. Bennett and R. Dolin (eds), Principles and Practice of Infectious Diseases, 6th edn. Philadelphia: Elsevier, pp. 3618-3624.

Madsen, J.M. and Darling, R.G. (2006). Future biologic and chemical weapons. In: G.R. Ciottone, P.D. Anderson, E. auf der Heide et al. (eds), Disaster Medicine. Philadelphia: Mosby, pp. 424-433.

McGough, M., Frank, L.L., Tipton, S. et al. (2005). Communicating the risks of bio-terrorism and other emergencies in a diverse society: a case study of special populations in North Dakota. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 3(3), 235-245.

Mermel, L.A. (2005). Pandemic avian influenza. Lancet Infectious Diseases 5(11), 666-667.

Meselson, M., Guillemin, J., Hugh-Jones, M. et al. (1994). The Sverdlovsk anthrax outbreak of 1979. Science 266, 1202-1208.

Middlebrook, J.L. (2005). Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Advanced Drug Delivery Reviews 57, 1415-1423.

Miller, J., Engelberg, S. and Broad, W. (2001). Germs: Biological Weapons and America's Secret War. New York: Simon and Schuster.

Mitchell, R. (1993). The Society of the Muslim Brothers. New York: Oxford University Press.

Moussalli, A.S. (1998). Introduction to Islamic fundamentalism: realities, ideologies and international politics. In: A.S. Moussalli (ed.), Islamic Fundamentalism: Myths and Realities. Reading: Garnet, pp. 3-39.

Nass, M. (1999). Anthrax vaccine. Model of a response to the biological warfare threat. Infectious Diseases Clinics of North America 13(1), 187-210.

Olson, K.B. (1999). Aum Shinrikyo: Once and future threat? Emerging Infectious Diseases 5(4), 513-516.

Opal, S.M., Artenstein, A.W., Cristofaro, P.A. et al. (2005). Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication. Infection and Immunity 73(8), 5101-5105.

Oyston, P.C.F. and Quarry, J.E. (2005). Tularemia vaccine: past, present and future. Antonie van Leeuwenhoek87, 277-281.

Oyston, P.C.F., Sjostedt, A. and Titbull, R.W. (2004). Tularemia: bioterrorism defense renews interest in Francisella tularensis. Nature Reviews Microbiology 2, 967-978.

Petro, J.B, Plasse, T.R. and McNulty, J.A. (2003). Biotechnology: impact on biological warfare and biodefense. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 1(3), 161-168.

Plaut, W.G. (1981). The Torah. New York: Union of American Hebrew Congregations.

Poland, G.R., Grabenstein, J.D. and Neff, J.M. (2005). The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine 23, 2078-2081.

Post, J.M. (2005). The new face of terrorism: socio-cultural foundations of contemporary terrorism. Behavioral Sciences and the Law23, 451-465.

Post, J.M., Sprinzak, E. and Denny, L.M. (2003). The terrorists in their own words: interviews with 35 incarcerated Middle Eastern terrorists. Terrorism and Political Violence 15, 171-184.

Ramalingaswami, V. (2001). Psychosocial effects of the 1994 plague outbreak in Saurat, India. Military Medicine 166, 29-30.

Rappert, B. (2003). Biological weapons, genetics, and social analysis: emerging responses, emerging issues - II. New Genetics and Society 22(3), 297-314.

Relman, D.A. (2006). Bioterrorism - preparing to fight the next war. New England Journal of Medicine 354, 113-115.

Ropeik, D. and Gray, G. (2002). Risk. Boston: Houghton Mifflin Company.

Rotz, L.D., Cono, J. and Damon, I. (2005). Smallpox and bioterrorism. In: G.L. Mandell, J.E. Bennett and R. Dolin (eds), Principles and Practice of Infectious Diseases, 6th edn. Philadelphia: Elsevier, pp. 3612-3617.

Saslaw, S., Eigelsbach, H.T., Prior, J.A. et al. (1961). Tularemia vaccine study. II. Respiratory challenge. Archives of Internal Medicine 107, 702-714.

Sidell, F.R., Takafuju, E.T. and Franz, D.R. (eds) (1997). Textbook of Military Medicine Series. Part I, Warfare, Weaponry and the Casualty. Washington, DC: Office of the Surgeon General, Department of the Army.

Steinbrook, R. (2005). Biomedical research and biosecurity. New England Journal of Medicine 353, 2212-2214.

Stepanov, A.V, Marinin, L.I., Pomerantsev, A.P. et al. (1996). Development of novel vaccines against anthrax in man. Journal of Biotechnology 44, 155-160.

Suffin, S.C., Carnes, W.H. and Kauffman, A.F. (1978). Inhalation anthrax in a home craftsman. Human Pathology 9, 594-597.

Svoboda, T., Henry, B., Shulman, L. et al. (2004). Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. New England Journal of Medicine 350, 2352-2361.

Taubenberger, J.K., Reid, A.H., Lourens, R.M. et al. (2005). Characterization of the 1918 influenza virus polymerase genes. Nature 437, 889-893.

Torok, T.J., Tauxe, R.V., Wise, R.P. et al. (1997). A large community outbreak of Salmonellosis caused by intentional contamination of restaurant salad bars. Journal of the American Medical Association 278, 389-395.

Tumpey, T.M., Basler, C.F., Aguilar, P.V. et al. (2005). Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80.

Twine, S., Bystrom, M., Chen, W. et al. (2005). A mutant of Francisella tularensis Strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infection and Immunity 73, 8345-8352.

United States Department of State (2002). Patterns of Global Terrorism 2001 Report. Available at: http://www.state.gov/s7ct/rls/crt.2001/html/ (accessed 3 April 2006).

Wehrle, P.F., Posch, J., Richter, K.H. et al. (1970). An outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bulletin of the World Health Organization 43, 669-679.

Weis, C.P., Intrepido, A.J., Miller, A.K. et al. (2002). Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US senate office. Journal of the American Medical Association 288(22), 2853-2858.

Wheelis, M. (2002). Biological warfare at the 1346 siege of Caffa. Emerging Infectious Diseases 8, 971-975.

Wiechman, D.J., Azarian, M. and Kendall, J.D. (1994) Islamic courts and corrections. International Journal of Comparative and Applied Criminal Justice 19, 33-47.

Witkowski, J.A. and Parish, L.C. (2002). The story of anthrax from antiquity to the present: a biological weapon of nature and humans. Clinics in Dermatology 20, 336-342.

World Health Organization (1970). Health Aspects of Chemical and Biological Weapons: Report of a WHO Group of Consultants. Geneva: World Health Organization, pp. 98-99.

World Health Organization (2005). Avian influenza a (H5N1) infection in humans. New England Journal of Medicine 353(13), 1374-1385.

Yehuda, R. (2002). Post-traumatic stress disorder. New England Journal of Medicine 346, 108-114.

Zilinskas, R.A. (1997). Iraq's biological weapons. The past as future? Journal of the American Medical Association 278, 418-424.

Swine Influenza

Swine Influenza

SWINE INFLUENZA frightening you? CONCERNED about the health implications? Coughs and Sneezes Spread Diseases! Stop The Swine Flu from Spreading. Follow the advice to keep your family and friends safe from this virus and not become another victim. These simple cost free guidelines will help you to protect yourself from the swine flu.

Get My Free Ebook


Post a comment